Discovery of a new class of PDE4B inhibitors with activity in adjuvant-induced arthritis model July 28, 2022
Health Canada clears QBKPN to enter clinic to restore innate immunity in elderly July 21, 2022 Qu Biologics has received clearance from Health Canada to proceed with a randomized, placebo-controlled trial of QBKPN, a first-in-class innate immune modulator that enhances lung immunity, in the elderly. Read More
NLRP11 identified as an essential component of the NLRP3 inflammasome in human macrophages June 22, 2022
RSS